ABSTRACT M€ uller glia are normally mitotically quiescent cells, but in certain pathological states they can re-enter the mitotic cell cycle. While several cell cycle regulators have been shown to be important in this process, a role for the tumor suppressor, p53, has not been demonstrated. Here, we investigated a role for p53 in limiting the ability of M€ uller glia to proliferate in the mature mouse retina. Our data demonstrate that M€ uller glia undergo a developmental restriction in their potential to proliferate. Retinal explants or dissociated cultures treated with EGF become mitotically quiescent by the end of the second postnatal week. In contrast, M€ uller glia from adult trp532/1 or trp532/2 mice displayed a greater ability to proliferate in response to EGF stimulation in vitro. The enhanced proliferative ability of trp53 deficient mice correlates with a decreased expression of the mitotic inhibitor Cdkn1a/p21 cip and an increase in c-myc, a transcription factor that promotes cell cycle progression. These data show that p53 plays an essential role in limiting the potential of M€ uller glia to re-enter the mitotic cycle as the retina matures during postnatal development. V
INTRODUCTION
Mammalian retinal progenitors undergo many rounds of cell division during development to produce the millions of neurons in the mature retina. After the first postnatal week, the progenitors withdraw from the mitotic cell cycle (Close et al., 2005; Rapaport et al., 2004; Young, 1985) . However, in certain pathological conditions, M€ uller glia in the mature retina can re-enter the mitotic cell cycle (see for review Karl and Reh, 2010) . Although even in these cases only a few M€ uller glia reenter the mitotic cycle in the mature mouse retina, those that do may contribute to a regenerative response (like that present in nonmammalian vertebrates; see review by Karl and Reh, 2010) or a pathological process (i.e., proliferative vitreo-retinopathy; see review by Bringmann et al., 2006 Bringmann et al., , 2009 . Therefore, a better understanding of the mechanisms that limit the proliferation of the M€ uller glia may lead to the development of strategies to stimulate retinal regeneration and prevent proliferative pathologies.
While much is known about the cell cycle proteins that regulate proliferation of the retinal progenitors (Chong et al., 2009) , the factors that regulate the transition from the high level of proliferation present in the developing retina to the mitotic quiescence of the M€ uller glia have received less attention. The cyclin dependent kinase inhibitor Cdkn1b/p27 kip , has been shown to be important in limiting the proliferation at the end of neurogenesis, and targeted deletion of this gene leads to excess proliferation of M€ uller glia (Dyer and Cepko, 2000; Levine et al., 2000) . In the rat retina, there are at least two extracellular signals that contribute to a reduction in proliferation after the first postnatal week: an increase in TGF-beta signaling and a decline in signaling through the EGFR pathway (Close et al., 2005 (Close et al., , 2006 . Together these signals lead to an increase in the level of p27 kip , which as mentioned above, normally acts to restrict M€ uller glial proliferation. Although these studies all implicate p27 kip as an important regulator of M€ uller glial proliferation, there is evidence that additional regulators are involved; deletion of Cdkn1b/p27 kip leads to only a small increase in M€ uller glial proliferation (Vazquez-Chona et al., 2011) and most M€ uller glia do not enter the mitotic cycle in the knock-out animals.
Recently, a genome-wide analysis of gene expression in developing M€ uller glia demonstrated that these cells are very similar to astrocytes (Nelson et al., 2011) ; therefore, analysis of regulators of astrocyte proliferation could lead to identification of factors that control proliferation in M€ uller glia. A key regulator of cell proliferation in astrocytes and adult neural stem cells is the tumor suppressor p53 (Bogler et al., 1999; Gil-Perotin et al., 2006; Meletis et al., 2006; Yahanda et al., 1995; Zheng et al., 2008) . While not thought to directly interact with the cell cycle proteins, p53 promotes cell cycle arrest by repressing c-myc transcription and by activating the Cdkn1a p21 cip , particularly after cell damage or stress (Cox and Lane, 1995; Ho et al., 2005; Kippin et al., 2005; Meletis et al., 2006; Zheng et al., 2008) .
We therefore investigated whether p53 might be involved in limiting the proliferation of M€ uller glia in the retina. We first assessed the ability of glia from wild-type mice to grow in explant and dissociated culture with epidermal growth factor (EGF) stimulation, and found that their ability to grow in vitro declines over the second postnatal week. To functionally test for a role of p53 in inhibiting M€ uller glial proliferation, we tested whether M€ uller cells from trp532/2 mice displayed the same developmental restriction in growth ability. We found that M€ uller glia from trp532/2 and trp531/2 mice have a much greater potential for mitotic proliferation in vitro, even when taken from adult mice. These results show that p53 is an important limiting factor for proliferation of M€ uller glia.
MATERIALS AND METHODS Mice
All animal procedures were approved by the IACUC at the University of Washington and housed in the Department of Comparative Medicine. Mice were C57BL/6, unless otherwise stated. Hes5-GFP transgenic mice (Basak and Taylor, 2007) were used to mark M€ uller glia in the retina (Nelson et al., 2011) . All trp532/2, trp531/2 (Donehower et al., 1992) and wild-type mice used for experiments were 4-to 6-weeks-old, and were littermates.
Retinal Explants
Retinas from postnatal mice at various ages were cultured as explants. Retinas were isolated in cold HBSS and placed onto a 0.4 lm pore tissue culture insert (Millipore). Each insert was placed in a 6-well plate, and explants were cultured for various periods. Half the media (DMEM/F12 supplemented with 1% dialyzed fetal bovine serum (FBS), 0.6% D1 glucose, 0.2% NaHCO 3 , 5 mM HEPES, L-glutamine (1 mM), 1 3 B27, and 1 3 N2) was changed daily, and recombinant mouse EGF (100 ng/mL; R&D systems) or vehicle (PBS) was also supplemented during each media change. BrdU (10 lg/mL; Sigma) or EdU (10 lg/mL; Invitrogen) was added to the media throughout the culture period.
NMDA Damage In Vivo
NMDA injury model was performed as described in Karl et al. (2008) . Briefly, mice were anesthetized deeply with ketamine (130 mg/kg) and xylazine (8.8 mg/kg), and a single intravitreal injection of NMDA (Sigma) was performed to induce retinal damage. Intravitreal injections of EGF and EdU were performed daily starting 2 days after NMDA injection for 4 days, and retinas were collected for immunohistochemical analyses 7 days after NMDA injection.
Dissociated M€ uller Glia Cell Culture
Postnatal day 12 (P12) M€ uller glia cultures were derived from pooled retinas of C57BL/6 littermates. Retinas were dissected after sacrifice and dissociated by placing into papain with 180 units/mL DNase (Worthington) and incubating at 37°C for 8-10 min. Cells were then briefly triturated, added to an equal volume of ovomucoid (Worthington), and spun at 300 g for 10 min at 4°C. Cells were plated in Neurobasal media, with 10% FBS (Clontech), 1 mM L-glutamine (Invitrogen), N2 (Invitrogen), 1% Penicilin-Streptomycin (Invitrogen), and EGF (100 ng/mL; R&D systems) at a density of two retinas per 10 cm 2 at 37°C in 5% CO 2 . Half of the media was changed every 2-3 days. 4-7 days after dissociation, cells were passaged with TrypLE (Invitrogen). For the adult M€ uller glia, retinas were dissected from 4-to 6-week-old trp532/2 and trp532/1 mice, dissociated, and cultured as described earlier. Adult cultures received 20 ng/mL EGF and were typically passaged every 4 days (plating 5,000 cells/cm 2 ). Seven days after initial dissociation, and every four days thereafter, cells were passaged and plated at a density of 5,000 cells/cm 2 . Cell counts were obtained using a hemocytometer, and total cell number was determined at each passage. Cells were cultured in 1% FBS and B27 (Invitrogen) for four days prior to harvest.
RNA Extraction/Microarray/RT Qpcr RNA was extracted from dissociated cells using Picopure RNA Isolation kit (Applied Biosystems). Affymetrix microarray analysis was carried out as described previously (Nelson et al., 2011) . Expression levels were compared with previously reported expression data from M€ uller glia (Nelson et al., 2011; Roesch et al., 2008) , astrocytes (Cahoy et al., 2008) , and endothelial cells (Bell et al., 2001 ). For qPCR, RNA was isolated from retinas or explants using Trizol (Invitrogen). cDNA synthesis was carried out using iScript cDNA synthesis kit (BioRad), and real-time qPCR was performed using SsoFast EvaGreen Supermix (BioRad). Gapdh was used as the normalization control. Fold change in expression as compared with control samples was calculated and plotted for the target gene. Significance (P < 0.05) was determined by a paired t-test. Primer sequences were as follows:
0 -GGCATTGCTCTCAATGACAA-3 0 , and Gapdh R 5 0 -CTTGCTCAGTGTCCTTGCTG-3 0 .
Immunohistochemistry
Cells or retinas were fixed with 2% paraformaldehyde. Fixed explants or retinas were cryoprotected in 30% sucrose/PBS at 4°C overnight, embedded in OCT compound (Sakura Finetek) , and sectioned at 12 lm using a cryostat. Immunohistochemistry (IHC) was carried out using standard protocols. EdU staining was performed following IHC using Click-iT EdU Alexa Fluor 555 or 647 imaging kit (Invitrogen). Imaging was performed using a confocal scanning microscope (Olympus). Primary antibodies used were: rat anti-BrdU (1:100, Accurate), chicken anti-GFP (1:500, Abcam), rabbit anti-Id1 (1:200, BioCheck), rabbit antiPax6 (1:600, Covance), mouse anti-s100b (1:1000, Sigma), rabbit anti-Sox2 (1:250, Abcam), rabbit anti-Sox9 (1:400, Millipore), and rabbit anti-GFAP (1:1000, Dako) antibodies. Goat or donkey antirabbit Alexa Fluor 568 (1:500, Invitrogen), goat antimouse 488 (1:400, Invitrogen), donkey antirabbit 488, a donkey antichicken 488 (Jackson Immunol, 1:500) and donkey antigoat 568 (1:400, Invitrogen) were used for secondary antibodies.
Western Blot
Each explant was homogenized in RIPA buffer. Prior to SDS-PAGE using 4-15% Tris-Glycine gradient gel (BioRad), each lysate was mixed with 53 sample buffer and boiled for 5 min. Proteins were transferred to a PVDF membrane, and Western blots were performed using a standard protocol. Primary antibodies used were: mouse anti-p27 (1:10,000, BD Transduction Labs) and mouse antibeta actin (1:20,000, Abcam). Anti-mouse HRP (1:10,000, BioRad) was used as a secondary antibody, and blots were exposed to X-ray films using SuperSignal West Dura Extended Duration Substrate (Thermo Scientific). Signals were quantified using ImageJ.
RESULTS

M€ uller Glia in Retina from Young Mice Proliferate in Explant Culture
The retinal progenitor cells that generate both the neurons and the M€ uller glia in the developing retina terminally differentiate in the first postnatal week in a central to peripheral gradient in mice and rats (Rapaport et al., 2004; Young, 1985) . The transition from proliferating progenitor to postmitotic M€ uller glia is in part regulated by extrinsic factors (e.g., EGF and TGF-beta) and intrinsic factors (e.g., p27
kip ). In the rat retina, a decline in EGF receptor on the M€ uller glia over the second and third postnatal weeks of development leads to the inability of EGF to stimulate their proliferation (Close et al., 2005 (Close et al., , 2006 . To determine whether this decline in the ability of EGF to stimulate proliferation of the M€ uller glia after the second postnatal week is true more generally in rodent retina, we carried out a series of explant culture experiments in developing mouse retina.
We assessed the degree of M€ uller glial proliferation in explant cultures from mouse retina isolated at different developmental times. When the mouse retina was isolated from P6 or P12 animals and cultured in the presence of EGF, there was a robust incorporation of the Sphase marker BrdU into the M€ uller glia after 7 days (Fig. 1A,B) . To verify that the proliferating cells were M€ uller glia, retinas from Hes5-GFP (Nelson et al., 2011) P12 mice were cultured for 5 days with EGF. EdU labeling colocalized with Hes5-GFP in these cultures (Fig.  1D,E) , indicating that proliferating cells were M€ uller glia. When the same experiment was carried out with retinas from P16 or older mice, there was little to no BrdU labeling (Fig. 1C) . Culture of retinal explants from mice at two-day intervals more clearly shows the time course of this decline in EGF-stimulated M€ uller glial proliferation (Fig. 1F ). There was a large decline between P8 and P10, and a further decline between P10 and P14, such that in retinas taken from animals older than P14, only a few M€ uller glia per section incorporated BrdU after 7 days in vitro in the presence of EGF. We also used the M-phase marker, PH3, and found it showed a similar decline as a function of the age of the mouse retina that was explanted (Fig. 1G) . The proliferation of M€ uller glia in the explant cultures required EGF, since without it there was little BrdU incorporation, even after 7 days (data not shown).
In most explant experiments, we assessed the number of M€ uller cells in the mitotic cycle at the end of 7 days of EGF treatment in vitro. However, to get a better idea of how soon the M€ uller glia re-enter the mitotic cell cycle after treatment with EGF in explants, we also assessed the number of BrdU1 and PH31 cells in P10 explants at each day of culture (Fig. 1H,I ). The first BrdU1 M€ uller glia were present after only 2 days in vitro, but their numbers steadily increase over the culture period (Fig. 1H ). M-phase (PH31) M€ uller glia were also observed after only 2 days in vitro, and their numbers appeared to reach a peak after 4 days; by 8 days there were few PH31 cells (Fig. 1I ). These data suggest that the M€ uller glia respond to the mitogen within a few days in vitro and continue to multiply for almost a week in the explants. However, even with the continued treatment with EGF, there appears to be a decline in M€ uller glial proliferation in explants cultured for more than a week. This may reflect some intrinsic limit to the number of cell cycles they can undergo, or may reflect technical limitations with the explant culture system.
M€ uller Glia from P12 Mice Grow Well in Dissociated Cultures
Although it is difficult to grow M€ uller glia from the mature mouse retina, and this has led investigators to use oncogenes to immortalize them for in vitro studies (e.g., Otteson and Phillips, 2010) , our results from the explant culture experiments suggested that M€ uller glia from retinas of mice less than 14 days postnatal might be better able to expand in vitro as dissociated cells than M€ uller glia isolated from adult animals. To test for this possibility, we dissociated retinas from P12 mice and plated the cells in medium containing serum and EGF. Most of the neurons did not survive when dissociated at this age, and the dead neurons were removed after the first day of culture; however, the M€ uller glia attached to the plate within the first 24 h and over the next 5 days expanded to form confluent monolayers ( Fig. 2A) . The cells were passaged after 4 days in vitro, and this further reduced the numbers of surviving neurons.
We analyzed the cultures using several different antibody markers of M€ uller glia, and by comparing their gene expression with freshly dissociated, FACS-sorted M€ uller glia from various ages of developing retina (data from Nelson et al., 2011) . After 5 days of culture, the vast majority of the cells were labeled for the M€ uller glial markers S100b, Id1, Pax6, and Sox2 ( Figs. 2A and  5A ). In addition, EdU labeling throughout the culture period showed that most of the M€ uller glia re-entered the cell cycle (92.4%1/2 3.9), consistent with the proliferation ability of M€ uller glia in explants of this age (Fig.  1) . Gene expression studies of M€ uller glia freshly isolated from retina have identified additional markers, including Glul, Vim, Sox9, Aqp4, Ctsh, Car2, Ccnd3, Dkk3, and Apoe. The gene expression analysis shows that nearly all of these were expressed at similar levels in the dissociated cell cultures as they were in the FACS-sorted M€ uller glia (Fig. 2B) . Since, the retina also contains other cell types-astrocytes and endothelial cells-that could potentially proliferate in dissociated cell cultures, we also used the gene expression data to determine whether these cells made up a significant contaminating population. Although astrocytes express many of the same genes as M€ uller glia, there is also a cohort of genes expressed specifically in astrocytes and not M€ uller glia. Expression of astrocyte-specific genes was low in dissociated M€ uller glial cultures, similar to the levels present in freshly isolated M€ uller glia (Fig.  2B) . Lastly, genes enriched in endothelial cells were not highly expressed in the dissociated M€ uller glial cultures (Fig. 2B) , and there were fewer than 1% SIB41 microglia/endothelial cells, so there appears to be only a low level of contamination from this source. Thus, the M€ uller glia in P12 mouse retina express most M€ uller glial markers at close to mature levels, but can still be expanded through at least one passage in vitro. In contrast, repeated attempts to establish M€ uller glia from mature mouse retina met with relatively little success. Thus, for both dissociated M€ uller cells and explant cultured M€ uller cells, there appears to be a developmental restriction in their ability to proliferate in vitro.
M€ uller Glia from trp532/2 or trp531/2 Mice Proliferate in Mature Mouse Retina In Vitro
The tumor suppressor p53 is a key regulator of cell proliferation in astrocytes. Since, M€ uller glial cells have an overall gene expression profile that is similar to astrocytes (Nelson et al., 2011) ; we postulated that their proliferation might also be regulated by p53. To test this hypothesis, we assessed M€ uller glial proliferation in adult wild-type, trp531/2 and trp532/2 mouse retinas, a stage when there is no M€ uller glial proliferation in wild-type mice (Fig. 1) . Previous studies have shown that while some of the trp532/2 mice die during embryogenesis, most survive and develop normally. No developmental phenotype has been identified in the trp531/2 mice. We analyzed the retinas of trp532/2 mature animals, and did not detect any gross developmental abnormalities (data not shown).
To assess a role for p53 in M€ uller glial proliferation, we set up explant cultures of adult (>6 week) mouse retinas from wild-type, trp531/2 and trp532/2 animals.
The retinas were cultured for 5 days, with EGF to stimulate M€ uller glial proliferation and EdU to label the Sphase cells. When we analyzed these cultures, there was a large increase in the number of EdU1 M€ uller glia (Pax61/Sox91) in the trp532/2 and trp531/2 mouse retinas (Figs. 3 and 4 ). There were a greater number of EdU1 M€ uller cells in the retinas from the trp532/2 when compared with the trp531/2 mice, and loss of a single allele of trp53 was sufficient to promote re-entry of the adult M€ uller glia into the mitotic cell cycle (Fig. 3) . The Pax61/EdU1 cells in the trp532/2 and trp531/2 retinas were present in both the INL, and the ONL (Fig.  3) , similar to the P12 explants (Fig. 1B,D ). There were also many cells in the ganglion cell layer that took up EdU that were not labeled with Pax6 or Sox9 (Fig. 3) ; we presume these are microglia or endothelial cells and they were not included in our analysis.
The above data show that the M€ uller glia in adult trp532/2 or trp532/1 mouse retina proliferate when placed in explant culture and treated with EGF. Figure  4 demonstrates that this effect requires EGF, since when this growth factor was not included in the medium, there was only a low level of proliferation (Fig.  4A,B) . Quantitation of the effect of EGF on proliferation of trp532/2 M€ uller glia revealed that over 10% of the Sox91 M€ uller glia re-enter the cell cycle upon EGF Fig. 3 . Loss of trp53 stimulates cell proliferation in adult retinal explants with EGF treatment for 5 days. trp532/2 adult retinal explants showed cell proliferation (EdU1 cells; red) when treated with EGF (lower panels), whereas wild-type explants did not (upper panels). trp531/2 explants showed intermediate level of cell proliferation (middle panels). EdU1 cells were primarily in the INL and ONL and were Pax61 (arrowheads). ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer. Scale bar: 50 lm. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary. com.] stimulation (Fig. 4C) . These results further suggest that neuronal damage, other than that which occurs from explant culture, is not required for the adult trp532/2 M€ uller glia to proliferate. Despite the robust proliferation observed in trp532/2 retinas in vitro, in vivo damage by NMDA and intraocular EGF injection failed to stimulate Muller glial proliferation over that observed in wild-type retinas (Fig. 4D) .
Glial cultures isolated from wild-type adult mice show very little, to no, ability to proliferate in dissociated cell cultures. To determine whether the effects of p53 loss that we observed on M€ uller glia in explant culture extended to dissociated cell culture, we enzymatically dissociated adult (>28 day) retinas from wild-type, trp531/2 and trp532/2 mice, and cultured the cells under similar conditions used for the P12 M€ uller glia. We saw no evidence of M€ uller glial cell proliferation in the wild-type cultures, though some cells survived for over one week (Fig. 5A) . However, in the trp532/2 or trp531/2 cultures, many of the M€ uller glia re-entered the mitotic cell cycle and within a week established confluent monolayers of cells (Fig. 5A) . The cells could be passaged for at least 4 weeks in trp531/2 mice, and for more than 8 weeks in trp532/2 mice. We calculated the doubling time for the trp532/2 to be 31-36 h and that of the trp531/2 to be greater than 60 h. We verified that the majority of cells in the cultures were M€ uller glia by using the same markers described above (Fig. 5B) . 
Mechanism of p53 Regulation of M€ uller Glial Proliferation
To determine the mechanism by which loss of p53 leads to increased M€ uller glial proliferation, we analyzed the expression of known p53 targets in an Affymetrix cDNA array dataset of wild-type glia isolated from Hes5-GFP1 mice (Nelson et al., 2011) . Several known p53 targets change substantially in M€ uller glia as they mature; in particular, members of the cyclin dependent kinase inhibitor family are upregulated in M€ uller cells in the first two postnatal weeks. In addition, two other well-established p53 targets, Btg2, a mitotic inhibitor, and Atf3, a p53 regulated transcription factor, also showed increases in expression in the M€ uller cells as they mature.
To determine whether any of these genes were relevant to the increase in M€ uller glial proliferation, we carried out qPCR of trp532/2 and wild-type retinas that had been cultured as explants for 5 days (Fig. 6A-D ). We found that the level of expression of Cdkn1a/p21 cip , was significantly higher in wild-type retinas than in trp532/2 retinas (Fig. 6A) . In addition, the levels of cmyc increased to a greater degree in the trp532/2 retinas than in the wild-type retinas (Fig. 6B) . These differences are enhanced by treatment with EGF. We also found that there was an increase in the p53 regulated transcription factor, Atf3, in the trp532/2 retinas (Fig.  6C) . By contrast, we did not observe a significant change in another p53 target, Btg2 (Fig. 6D) . The effects of the loss of p53 on M€ uller glia were not due to a reduction in the cell cycle regulator p27 kip (Fig. 6E,F) , suggesting that the p53-regulated pathways relevant to M€ uller glial proliferation are independent of the previously characterized p27 kip regulation. Together, our data support a model in which p53 normally leads to an inhibition of M€ uller glial proliferation through an increase in the mitotic inhibitor Cdkn1a/p21 cip and a repression of the cell cycle progression factor, c-myc. In addition to these changes in gene expression, we also analyzed the trp532/2 retinas for signs of reactive gliosis. Targeted deletion of cell cycle regulators has been shown to lead to M€ uller glial reactivity (Levine et al., 2000; VazquezChona et al., 2011) , and loss of trp53 could have similar effects. Indeed, when we analyzed the trp532/2 retinas for GFAP expression, we found that both with qPCR and immunofluorescence, there was an increase in expression of this marker of reactive gliosis (Fig. 7A,B) .
DISCUSSION
We have found that M€ uller glia from mouse retina undergo a developmental restriction in their ability to re-enter the mitotic cell cycle in the second postnatal week, even in the presence of high levels of EGF. This phenomenon occurs in both explant cultures and dissociated cell cultures. However, in trp532/2 and trp531/2 mice this developmental restriction no longer occurs and M€ uller glia can be stimulated to divide in the presence of EGF even in mature retina, possibly through a reduced expression of the cyclin dependent kinase inhibitor p21 cip /Cdkn1a, or through an increase in expression of c-myc.
During retinal development, the progenitors undergo extensive cell divisions to generate the large number of retinal cells that comprise this tissue. At the end of the first postnatal week, however, most of the progenitor cells have withdrawn from the cell cycle in mice and rats, and the neurons remain postmitotic throughout life. In contrast, while the M€ uller glia does not actively proliferate in the mature retina, they retain competence to re-enter the mitotic cell cycle in response to mitogens for almost a week after they have been generated. Nevertheless, adding even high levels of EGF to either explant or dissociated cell cultures of mouse M€ uller glia after P12 does not stimulate their proliferation. A similar developmental decline has been previously reported in the rat retina, and this is mediated in part by an increase in the response of the cells to TGF-beta signaling and a decline in their responsiveness to EGF (Close et al., 2006) . Our data suggest that this decline in M€ uller glial response to EGF and other mitogens might be due in part to a p53 mediated increase in p21 cip and a concomitant decrease in c-myc expression.
Previous studies have implicated Cdki's in the inhibition of cell proliferation in M€ uller glia. The cell cycle regulator p27 kip has been shown to be critical for the kip protein expression in adult wild-type and trp532/2 explants with or without EGF treatment was quantified and plotted. Loss of p53 does not affect p27 kip expression in adult retinal explants. *P < 0.05 with paired t-test (n 5 3). Error bars are in SEM. GFAP expression in wild-type adult retina was limited to M€ uller cell endfeet (upper panels). Scale bar: 50 lm. ONH, optic nerve head. (B) qPCR shows significant increase in Gfap mRNA expression in trp532/2 retinas compared with wild-type littermates. Gapdh was the normalization control. *P < 0.01. Error bars are in SEM (n 5 9). maintenance of M€ uller glia in a mitotically quiescent state (Levine et al., 2000) . Loss of this gene, even in mature animals, leads to a re-entry of M€ uller glia into the cell cycle (V azquez-Chona et al., 2011) . In our analysis of trp532/2 mice, we did not observe changes in expression of p27 kip (Fig. 6E,F) , but rather we found that a related gene, Cdkn1a/p21 cip , was significantly down-regulated in the trp532/2 retina (Fig. 6A) . These results suggest that these two Cdki's may both be necessary for regulating M€ uller glial proliferation, though p53 likely affects the expression of a large number of genes, and the effects on Cdkn1a/p21 cip may only partly be responsible for the trp532/2 phenotype in the M€ uller glia.
Previous studies have shown that p53 is a key regulator of cell proliferation in CNS glia and adult neural stem cells (Bogler et al., 1999; Gil-Perotin et al., 2006; Meletis et al., 2006; Yahanda et al., 1995; Zheng et al., 2008) . The mechanisms by which p53 inhibits M€ uller glial proliferation may be similar to those operating in astrocytes or adult neural stem cells. In astrocytes, p53 promotes cell cycle arrest by repressing c-myc transcription and/or by activating the cyclin dependent kinase inhibitor p21 cip /Cdkn1a (Cox and Lane, 1995; Ho et al., 2005; Kippin et al., 2005; Meletis et al., 2006; Zheng et al., 2008) . The activation of Cdkn1a/p21 cip by p53 is likely to be direct, while there is evidence that p53 represses c-myc expression via indirect mechanisms (Cannell et al., 2010; Sachdeva et al., 2009 ). In the trp532/2 M€ uller glia, we found an increase in c-myc and a reduction in Cdkn1a/p21 cip . In the brain of trp532/2 mice, similar changes in astrocytes are thought to lead to astrocytomas (Zheng et al., 2008) . We have not found evidence of glial tumors in the retinas of the trp532/2 mice; however, we have observed an increase in GFAP expression, somewhat analogous to that observed in the Cdkn1b/p27 kip knockout mice (Levine et al., 2000; V azquez-Chona et al., 2011) , suggesting that some of the same downstream effects may occur with perturbations in these pathways. Thus, although M€ uller glia and astrocytes share a common role for p53 in the regulation of c-myc, p21 cip /Cdkn1a and possibly other cell cycle regulatory genes, M€ uller glia appear to have additional inhibitors of cell proliferation that are active in vivo.
Consistent with the possibility that there are additional regulators of proliferation in M€ uller glia are our own in vivo experiments in the trp532/2 mice. Although there is a robust proliferative response in vitro, we failed to see this same effect in vivo, even after multiple injections of mitogenic factors. These results suggest that the in vitro environment reduces the effectiveness of these additional mitotic inhibitors, perhaps by down-regulating known inhibitory factors, like p27 kip or alternatively by up-regulating factors that promote re-entry into the mitotic cell cycle, such as cyclinD1. Further studies of the changes that occur upon explant culturing the retina may allow the identification of the additional regulatory factors.
